NOV (NOV)
(Delayed Data from NYSE)
$18.87 USD
-0.08 (-0.42%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $18.87 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth F Momentum B VGM
Price, Consensus and EPS Surprise
NOV 18.87 -0.08(-0.42%)
Will NOV be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for NOV based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NOV
Nov Inc. (NOV) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Nov Inc. (NOV) Tops Q1 Earnings and Revenue Estimates
NOV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Trane Technologies (TT) Earnings Expected to Grow: Should You Buy?
Earnings Preview: Nov Inc. (NOV) Q1 Earnings Expected to Decline
Arcosa (ACA) Buys Ameron, Expands Infrastructure Portfolio
Other News for NOV
NOV Inc. (NOV) Q1 2024 Earnings: Surpasses Revenue Projections but Misses on EPS
NOV Announces Capital Return Plan and Enhanced Shareholder Rewards
NOV (NOV) Receives a Buy from Stifel Nicolaus
NOV Inc. stock outperforms competitors despite losses on the day
Analysts Conflicted on These Energy Names: NOV (NOV) and Baker Hughes Company (BKR)